Increasing geriatric population and prevalence of sleep disorders are significantly sustaining sleep aids market growth, with the market anticipated to be valued at US$ 23.5 Billion in 2019. The sleep aids market is expected to exhibit a CAGR of 5% during the forecast period of 2019-2029. Sleep is a biological requirement that maintains metabolic homeostasis, influences memory and other cognitive function, and regulates immune function. Sleep aids are drugs and medical devices used to diagnose and treat various sleep disorders, such as sleep apnea and insomnia.

Asia Pacific sleep aids market is estimated to witness remunerative growth over the forecast period due to the increasing geriatric population that is more susceptible to sleep disorders. Nearly 18 million individuals are suffering from sleep deficiency that is interfering with their job performance as well as personal life too. The reported study estimated the sleep aids market to reach up to USD 114.15 billion in 2025, with a compound annual growth rate of 7.0% over the forecast period (2019-2025).

The major factor driving the preference of mattresses and pillows is the better availability and specially developed for treating sleeping disorders are easily available in many departmental or specialty stores. These are Preferred More than Other Types of Sleep Aids. About 70% of adults globally experience at least one sleep disorder. Insomnia affects between 30-45% of the adult population. The market is attributed to the presence of large multinational players as well as a few smaller and local players.

Segmentation Analysis: By Product:

Mattress and Pillow

Medications

Sleep Apnea Device

Restless Leg Syndrome

By Geography:

Europe

Asia Pacific

Europe

North America

By Disorder:

Sleep Apnea

Sleep Walking

Insomnia

By Medication type:

Drugs (based on prescription)

Herbal Drugs

Others

Narcolepsy

Key Players:

Sanofi

Pfizer Inc.

Koninklijke Philips N.V.

GlaxoSmithKline plc

Cadwell

SleepMed

Care Fusion Corp.

Others.